OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Nicolás Roche, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2200803-2200803
Open Access | Times Cited: 34
Nicolás Roche, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2200803-2200803
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Antiviral Therapy of COVID-19
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
Τheodoros Karampitsakos, Ουρανία Παπαϊωάννου, Panagiota Tsiri, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 3, pp. 372-378
Open Access | Times Cited: 34
Τheodoros Karampitsakos, Ουρανία Παπαϊωάννου, Panagiota Tsiri, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 3, pp. 372-378
Open Access | Times Cited: 34
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Charles Haworth, Michal Shteinberg, Kevin Winthrop, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 10, pp. 787-798
Open Access | Times Cited: 5
Charles Haworth, Michal Shteinberg, Kevin Winthrop, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 10, pp. 787-798
Open Access | Times Cited: 5
Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience
Dragana Sokolović, Dragana Drakul, Vesna Vujić‐Aleksić, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Dragana Sokolović, Dragana Drakul, Vesna Vujić‐Aleksić, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Pharmacological approaches to pulmonary fibrosis following COVID-19
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?
Andrea S. Melani, Sara Croce, Lucia Cassai, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 329-344
Open Access | Times Cited: 11
Andrea S. Melani, Sara Croce, Lucia Cassai, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 329-344
Open Access | Times Cited: 11
Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106217-106217
Closed Access | Times Cited: 2
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106217-106217
Closed Access | Times Cited: 2
Five sessions of Hyperbaric Oxygen for critically ill patients with COVID-19-induced ARDS: a randomised, open label, phase II trial.
Anders Kjellberg, Johan Douglas, Michael Pawlik, et al.
Respiratory Medicine (2024) Vol. 232, pp. 107744-107744
Open Access | Times Cited: 2
Anders Kjellberg, Johan Douglas, Michael Pawlik, et al.
Respiratory Medicine (2024) Vol. 232, pp. 107744-107744
Open Access | Times Cited: 2
Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
Fernando dos Santos, Joyce B. Li, Nathalia Juocys, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 7
Fernando dos Santos, Joyce B. Li, Nathalia Juocys, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 7
Critical appraisal of clinical practice guidelines
Jeppe Bennekou Schroll, Britta Tendal Jeppesen, Morten Hylander Møller, et al.
Ugeskrift for Læger (2024) Vol. 186, Iss. 6, pp. 1-8
Open Access | Times Cited: 1
Jeppe Bennekou Schroll, Britta Tendal Jeppesen, Morten Hylander Møller, et al.
Ugeskrift for Læger (2024) Vol. 186, Iss. 6, pp. 1-8
Open Access | Times Cited: 1
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial
Merete Long, Hani Abo-Leyah, Yan Hui Giam, et al.
ERJ Open Research (2024) Vol. 10, Iss. 2, pp. 00917-2023
Open Access | Times Cited: 1
Merete Long, Hani Abo-Leyah, Yan Hui Giam, et al.
ERJ Open Research (2024) Vol. 10, Iss. 2, pp. 00917-2023
Open Access | Times Cited: 1
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Consumption of Antibiotics in Primary Care Setting before and during COVID-19 Pandemic in Republic of Srpska, Bosnia and Herzegovina
Dragana Sokolović, Dragana Drakul, Bojan Joksimović, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1319-1319
Open Access | Times Cited: 7
Dragana Sokolović, Dragana Drakul, Bojan Joksimović, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1319-1319
Open Access | Times Cited: 7
Challenges and Opportunities Associated with Lifting the Zero COVID-19 Policy in China
Kun Hu, Lanjing Zhang
Exploratory Research and Hypothesis in Medicine (2023) Vol. 9, Iss. 1, pp. 32-36
Open Access | Times Cited: 3
Kun Hu, Lanjing Zhang
Exploratory Research and Hypothesis in Medicine (2023) Vol. 9, Iss. 1, pp. 32-36
Open Access | Times Cited: 3
Host-Based Treatments for Severe COVID-19
Lucrezia Mondini, Francesco Salton, Liliana Trotta, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3102-3121
Open Access | Times Cited: 3
Lucrezia Mondini, Francesco Salton, Liliana Trotta, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3102-3121
Open Access | Times Cited: 3
Serial lung ultrasound in monitoring viral pneumonia: the lesson learned from COVID-19
David Clofent, Mario Culebras, Almudena Felipe Montiel, et al.
ERJ Open Research (2023) Vol. 9, Iss. 4, pp. 00017-2023
Open Access | Times Cited: 3
David Clofent, Mario Culebras, Almudena Felipe Montiel, et al.
ERJ Open Research (2023) Vol. 9, Iss. 4, pp. 00017-2023
Open Access | Times Cited: 3
TheEuropean Respiratory Journal: the ERS flagship heads for the next frontier
James D. Chalmers, Don D. Sin
European Respiratory Journal (2023) Vol. 61, Iss. 1, pp. 2202475-2202475
Closed Access | Times Cited: 2
James D. Chalmers, Don D. Sin
European Respiratory Journal (2023) Vol. 61, Iss. 1, pp. 2202475-2202475
Closed Access | Times Cited: 2
A leap towards personalised therapy of acute lung injury
Martin Witzenrath, Tobias Welte
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2201808-2201808
Closed Access | Times Cited: 4
Martin Witzenrath, Tobias Welte
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2201808-2201808
Closed Access | Times Cited: 4
Validation of the qSOFA and CRB-65 in SARS-CoV-2 infected community-acquired pneumonia
Tina Richter, Falko Tesch, Jochen Schmitt, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00168-2023
Open Access | Times Cited: 2
Tina Richter, Falko Tesch, Jochen Schmitt, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00168-2023
Open Access | Times Cited: 2
Gravidade e desfechos de pacientes críticos com COVID-19 antes e após a emergência das variantes de preocupação: uma comparação entre duas ondas pandêmicas
Daniela Helena Machado Freitas
(2024)
Open Access
Daniela Helena Machado Freitas
(2024)
Open Access
Murder, she wrote: a long story on long COVID is being written
Joan B. Soriano, Julio Ancochea
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2400916-2400916
Closed Access
Joan B. Soriano, Julio Ancochea
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2400916-2400916
Closed Access
Management of severe COVID-19 in the ICU
Despoina Koulenti, Maria Panagiota Almyroudi, Ioannis Andrianopoulos, et al.
European Respiratory Society eBooks (2024)
Closed Access
Despoina Koulenti, Maria Panagiota Almyroudi, Ioannis Andrianopoulos, et al.
European Respiratory Society eBooks (2024)
Closed Access
Step-Based Dosing of Anticoagulants in COVID-19 Treatment
Minh-Hoang Tran, Hoang Hai Nguyen, Quang Trung Nguyen, et al.
Cureus (2024)
Open Access
Minh-Hoang Tran, Hoang Hai Nguyen, Quang Trung Nguyen, et al.
Cureus (2024)
Open Access
Factors Influencing the Length of Hospital Stay Among Pediatric COVID-19 Patients at Queen Rania Al Abdullah Hospital for Children: A Cross-Sectional Study
Alia M Al-Khlaifat, Asmaa M Al Quraan, Aseel F Nimri, et al.
Cureus (2023)
Open Access | Times Cited: 1
Alia M Al-Khlaifat, Asmaa M Al Quraan, Aseel F Nimri, et al.
Cureus (2023)
Open Access | Times Cited: 1
High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
Marlene Ettemeyer, M. E. Florey, Konstantin Tanida, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1569-1575
Open Access | Times Cited: 1
Marlene Ettemeyer, M. E. Florey, Konstantin Tanida, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1569-1575
Open Access | Times Cited: 1
